Naeem Hashmi, MD; PHD
Internal Medicine · Palo Alto
- Medicare standing
- 5 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Banned from treating people on Medicare
- Medicare cancelled their billing
- Medicare does not list them as allowed to order and refer
- California licence: Surrendered
- 3 Medical Board actions on record
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Naeem Hashmi’s office at (650) 493-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A76894 · Surrendered
Licence status: Surrendered · since 2001 · University of the Punjab, King Edward Medical College. Board flags: Felony Conviction, Hospital Discipline Per B&P Cde Sect 805.
Licensee has surrendered his or her license to resolve a disciplinary or licensing action. No practice is permitted.
Public record actions
| 2026-03-24 | Board disciplineDiscipline | Surrender of license. · 8002021084464 |
| 2025-04-16 | Felony convictionDiscipline | Pled guilty to two counts of violating penal code ? 288(A), lewd and lascivious acts with a minor under the age of fourteen years old, and two counts of violation penal code ? 243.4, sexual battery. · Superior court of california, county of santa clara · B2102827 · Pending sentencing on october 27, 2025. |
| 2023-12-11 | Hospital disciplineDiscipline | Termination or revocation of staff privileges · Physician's Medical Group of San Jose |
Original Medicare doctor bills
$19,557
Medicare paid this office $19,557 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 31 | $11,423 | $102 |
| Short return visit (20+ min) | 26 | $7,391 | $77 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of needle into vein (3 years or older) | 37 | 39 | 47 | 25 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 75 · Women 36% · Health risk score 0.94. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 39%.
The office billed $32,316, Medicare allowed $28,231 and paid $19,557; for 229 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 229 | 75 | 0.94 | $32,316 | $19,557 |
| 2023 | 37 | 132 | 74 | 0.75 | $16,135 | $10,707 |
| 2022 | 74 | 356 | 73 | 0.75 | $42,871 | $26,049 |
| 2021 | 91 | 549 | 73 | 0.80 | $70,387 | $48,877 |
| 2020 | 82 | 559 | 73 | 0.92 | $71,278 | $43,075 |
| 2019 | 85 | 609 | 73 | 1.06 | $73,329 | $46,295 |
| 2018 | 75 | 477 | 73 | 0.89 | $56,093 | $30,492 |
| 2017 | 78 | 491 | 72 | 0.82 | $55,895 | $33,252 |
| 2016 | 77 | 504 | 73 | 0.83 | $59,234 | $33,837 |
| 2015 | 69 | 358 | 72 | 1.00 | $46,862 | $28,940 |
| 2014 | 84 | 308 | 73 | 0.89 | $46,525 | $27,886 |
| 2013 | 55 | 150 | 70 | 0.73 | $24,028 | $15,252 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 23 | $3,855 | $82 |
| Return visit (30+ min) | 22 | $3,457 | $105 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,019 | $73 |
2022: 5 services
| Return visit (30+ min) | 45 | $10,468 | $104 |
| Short return visit (20+ min) | 49 | $8,464 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,756 | $160 |
| Short return visit | 26 | $1,746 | $47 |
| Insertion of needle into vein (3 years or older) | 19 | $383 | $15 |
2021: 6 services
| Return visit (30+ min) | 72 | $24,521 | $110 |
| Short return visit (20+ min) | 56 | $11,573 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,858 | $161 |
| New patient visit (45+ min) | 20 | $2,758 | $138 |
| Insertion of needle into vein (3 years or older) | 30 | $797 | $17 |
| Short return visit | 12 | $728 | $56 |
2020: 7 services
| Return visit (30+ min) | 58 | $18,535 | $97 |
| Short return visit (20+ min) | 55 | $10,340 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,679 | $142 |
| New patient visit (45+ min) | 17 | $2,188 | $129 |
| Long return visit (40+ min) | 11 | $1,824 | $140 |
| Insertion of needle into vein (3 years or older) | 25 | $624 | $16 |
| Short return visit | 13 | $549 | $34 |
2019: 9 services
| Return visit (30+ min) | 64 | $20,541 | $100 |
| Short return visit (20+ min) | 50 | $8,769 | $67 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $5,007 | $139 |
| New patient visit (45+ min) | 28 | $3,870 | $138 |
| Long return visit (40+ min) | 13 | $2,459 | $137 |
| Short return visit | 11 | $652 | $41 |
| Insertion of needle into vein (3 years or older) | 24 | $606 | $16 |
| Injection of drug or substance under skin or into muscle | 12 | $394 | $16 |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $10 | None |
2018: 7 services
| Return visit (30+ min) | 50 | $12,313 | $88 |
| Short return visit (20+ min) | 41 | $7,019 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,566 | $132 |
| New patient visit (45+ min) | 16 | $1,879 | $117 |
| Short return visit | 13 | $602 | $35 |
| Insertion of needle into vein (3 years or older) | 18 | $432 | $15 |
| Insertion of needle into vein for collection of blood sample | 22 | $65 | $3 |
2017: 8 services
| Return visit (30+ min) | 46 | $12,565 | $90 |
| Long return visit (40+ min) | 26 | $4,414 | $123 |
| Short return visit (20+ min) | 36 | $4,296 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $3,872 | $129 |
| New patient visit (45+ min) | 22 | $3,051 | $139 |
| Insertion of needle into vein (3 years or older) | 26 | $488 | $15 |
| Injection of drug or substance under skin or into muscle | 12 | $433 | $23 |
| Insertion of needle into vein for collection of blood sample | 22 | $68 | $3 |
2016: 9 services
| Return visit (30+ min) | 43 | $13,150 | $97 |
| Short return visit (20+ min) | 39 | $7,018 | $66 |
| Long return visit (40+ min) | 28 | $4,643 | $129 |
| New patient visit (45+ min) | 18 | $2,146 | $119 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,586 | $132 |
| New patient visit (30+ min) | 15 | $1,337 | $89 |
| Injection of drug or substance under skin or into muscle | 16 | $682 | $24 |
| Insertion of needle into vein (3 years or older) | 15 | $313 | $16 |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $31 | None |
2015: 5 services
| Return visit (30+ min) | 40 | $10,632 | $94 |
| Long return visit (40+ min) | 27 | $7,930 | $130 |
| New patient visit (45+ min) | 32 | $4,608 | $144 |
| Short return visit (20+ min) | 19 | $2,037 | $62 |
| Insertion of needle into vein (3 years or older) | 12 | $255 | $16 |
2014: 6 services
| Return visit (30+ min) | 36 | $7,706 | $96 |
| Long return visit (40+ min) | 24 | $5,324 | $124 |
| New patient visit (45+ min) | 33 | $4,912 | $149 |
| Short return visit (20+ min) | 25 | $2,845 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,617 | $135 |
| Insertion of needle into vein (3 years or older) | 12 | $289 | $16 |
2013: 3 services
| Long return visit (40+ min) | 28 | $6,134 | $125 |
| New patient visit (45+ min) | 28 | $4,022 | $144 |
| New patient visit (60+ min) | 12 | $2,080 | $173 |
Drugs they prescribed that Part D paid
$25,004
Pharmacies billed $25,004 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (11 of 253) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
213 generic and 40 brand-name prescriptions · $25,004 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pregabalin | 12 | $1,898 | $158 |
| Amlodipine Besylate | 11 | $143 | $13 |
| Atorvastatin | 15 | $89 | $6 |
| Gabapentin | 20 | $88 | $4 |
| Metformin | 21 | $69 | $3 |
See all 6 drugs
| Pregabalin | 12 | $1,898 | $158 |
| Amlodipine Besylate | 11 | $143 | $13 |
| Atorvastatin | 15 | $89 | $6 |
| Gabapentin | 20 | $88 | $4 |
| Metformin | 21 | $69 | $3 |
| Hydrocodone-Acetaminophen | 11 | $39 | $4 |
Year by year
| 2024 | 253 | 41 | 4% (11) | 16% | $25,004 |
| 2023 | 236 | 52 | None | None | $23,496 |
| 2022 | 567 | 104 | None | None | $45,791 |
| 2021 | 887 | 120 | None | None | $42,937 |
| 2020 | 692 | 104 | None | 13% | $30,039 |
| 2019 | 542 | 91 | None | None | $19,598 |
| 2018 | 518 | 96 | None | 17% | $18,275 |
| 2017 | 647 | 104 | None | 18% | $28,877 |
| 2016 | 674 | 102 | None | None | $45,313 |
| 2015 | 590 | 94 | None | None | $32,027 |
| 2014 | 573 | 83 | 4% (23) | None | $26,806 |
| 2013 | 242 | 67 | 6% (14) | None | $15,184 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Atorvastatin | 28 | $432 | $15 |
| Lisinopril | 21 | $307 | $15 |
| Amlodipine Besylate | 12 | $225 | $19 |
| Metformin | 19 | $140 | $7 |
2022: 12 drugs
| Gabapentin | 15 | $1,224 | $82 |
| Levothyroxine | 21 | $398 | $19 |
| Tamsulosin | 22 | $382 | $17 |
| Amlodipine Besylate | 46 | $312 | $7 |
| Losartan | 25 | $312 | $12 |
| Atorvastatin | 33 | $303 | $9 |
| Metformin | 31 | $297 | $10 |
| Lisinopril | 42 | $281 | $7 |
| Simvastatin | 11 | $81 | $7 |
| Metoprolol | 12 | $56 | $5 |
| Cyclobenzaprine | 11 | $55 | $5 |
| Hydrochlorothiazide | 15 | $44 | $3 |
2021: 17 drugs
| Levothyroxine | 42 | $811 | $19 |
| Losartan | 41 | $592 | $14 |
| Atorvastatin | 37 | $551 | $15 |
| Lisinopril | 60 | $547 | $9 |
| Amlodipine Besylate | 54 | $468 | $9 |
| Tamsulosin | 28 | $430 | $15 |
| Omeprazole | 21 | $412 | $20 |
| Metformin | 45 | $324 | $7 |
| Metoprolol | 11 | $226 | $21 |
| Simvastatin | 25 | $201 | $8 |
| Gabapentin | 22 | $195 | $9 |
| Hydrochlorothiazide | 14 | $152 | $11 |
| Lisinopril-Hydrochlorothiazide | 15 | $140 | $9 |
| Azithromycin | 12 | $87 | $7 |
| Metoprolol | 13 | $81 | $6 |
| Cyclobenzaprine | 17 | $39 | $2 |
| Alprazolam | 14 | $34 | $2 |
2020: 19 drugs
| Flovent Diskus | 12 | $3,258 | $272 |
| Oseltamivir Phosphate | 11 | $749 | $68 |
| Levothyroxine | 31 | $731 | $24 |
| Losartan | 28 | $538 | $19 |
| Lisinopril | 50 | $434 | $9 |
| Atorvastatin | 27 | $389 | $14 |
| Metoprolol | 16 | $387 | $24 |
| Omeprazole | 19 | $370 | $19 |
| Allopurinol | 12 | $290 | $24 |
| Amlodipine Besylate | 39 | $278 | $7 |
| Fluticasone Propionate | 11 | $162 | $15 |
| Simvastatin | 17 | $154 | $9 |
| Gabapentin | 17 | $132 | $8 |
| Metformin | 19 | $125 | $7 |
| Tamsulosin | 12 | $124 | $10 |
| Azithromycin | 21 | $123 | $6 |
| Cyclobenzaprine | 19 | $110 | $6 |
| Lovastatin | 12 | $99 | $8 |
| Pantoprazole | 12 | $56 | $5 |
2019: 10 drugs
| Levothyroxine | 31 | $864 | $28 |
| Atorvastatin | 26 | $395 | $15 |
| Lisinopril | 50 | $360 | $7 |
| Omeprazole | 12 | $266 | $22 |
| Amlodipine Besylate | 35 | $264 | $8 |
| Losartan | 15 | $263 | $18 |
| Simvastatin | 21 | $200 | $10 |
| Azithromycin | 19 | $166 | $9 |
| Metformin | 11 | $112 | $10 |
| Cyclobenzaprine | 12 | $56 | $5 |
2018: 10 drugs
| Metoprolol | 18 | $503 | $28 |
| Atorvastatin | 29 | $473 | $16 |
| Levothyroxine | 29 | $437 | $15 |
| Lisinopril | 30 | $399 | $13 |
| Amlodipine Besylate | 34 | $265 | $8 |
| Simvastatin | 17 | $245 | $14 |
| Azithromycin | 25 | $185 | $7 |
| Fluticasone Propionate | 11 | $141 | $13 |
| Metformin | 11 | $106 | $10 |
| Metoprolol | 11 | $74 | $7 |
2017: 13 drugs
| Creon | 18 | $2,185 | $121 |
| Rosuvastatin | 11 | $1,036 | $94 |
| Levothyroxine | 47 | $785 | $17 |
| Atorvastatin | 34 | $502 | $15 |
| Sucralfate | 11 | $322 | $29 |
| Metoprolol | 15 | $318 | $21 |
| Lisinopril | 41 | $283 | $7 |
| Simvastatin | 23 | $276 | $12 |
| Amlodipine Besylate | 32 | $273 | $9 |
| Omeprazole | 30 | $193 | $6 |
| Azithromycin | 21 | $120 | $6 |
| Losartan | 12 | $70 | $6 |
| Trazodone | 11 | $47 | $4 |
2016: 15 drugs
| Fenofibrate | 15 | $1,096 | $73 |
| Levothyroxine | 27 | $613 | $23 |
| Oxybutynin Chloride Er | 13 | $399 | $31 |
| Lisinopril | 44 | $398 | $9 |
| Atorvastatin | 23 | $345 | $15 |
| Dextroamphetamine-Amphetamine | 12 | $327 | $27 |
| Simvastatin | 22 | $287 | $13 |
| Amlodipine Besylate | 33 | $285 | $9 |
| Allopurinol | 12 | $271 | $23 |
| Sucralfate | 11 | $236 | $21 |
| Metformin | 19 | $205 | $11 |
| Omeprazole | 18 | $193 | $11 |
| Fluticasone Propionate | 14 | $144 | $10 |
| Losartan | 16 | $139 | $9 |
| Azithromycin | 18 | $134 | $7 |
2015: 16 drugs
| Proair Hfa | 15 | $787 | $52 |
| Levothyroxine | 14 | $405 | $29 |
| Dextroamphetamine-Amphetamine | 13 | $345 | $27 |
| Omeprazole | 16 | $320 | $20 |
| Lisinopril | 40 | $309 | $8 |
| Losartan | 14 | $275 | $20 |
| Atorvastatin | 11 | $275 | $25 |
| Fluticasone Propionate | 22 | $229 | $10 |
| Amlodipine Besylate | 34 | $229 | $7 |
| Metformin | 23 | $188 | $8 |
| Allopurinol | 11 | $152 | $14 |
| Alendronate | 15 | $132 | $9 |
| Azithromycin | 23 | $130 | $6 |
| Simvastatin | 15 | $61 | $4 |
| Atenolol | 13 | $57 | $4 |
| Hydrochlorothiazide | 16 | $49 | $3 |
2014: 16 drugs
| Proair Hfa | 17 | $867 | $51 |
| Levothyroxine | 14 | $442 | $32 |
| Omeprazole | 16 | $366 | $23 |
| Atorvastatin | 13 | $281 | $22 |
| Metformin | 26 | $247 | $10 |
| Losartan | 21 | $219 | $10 |
| Hydrocodone-Acetaminophen | 21 | $173 | $8 |
| Lisinopril | 26 | $170 | $7 |
| Pantoprazole | 14 | $163 | $12 |
| Simvastatin | 18 | $158 | $9 |
| Azithromycin | 19 | $156 | $8 |
| Alendronate | 14 | $156 | $11 |
| Amlodipine Besylate | 22 | $139 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $117 | $11 |
| Gabapentin | 14 | $110 | $8 |
| Furosemide | 13 | $54 | $4 |
2013: 4 drugs
| Losartan | 15 | $281 | $19 |
| Azithromycin | 17 | $133 | $8 |
| Amlodipine Besylate | 17 | $130 | $8 |
| Hydrocodone-Acetaminophen | 11 | $64 | $6 |
Money from drug and device companies
$114 in 2021
| 2021 | 5 | 5 | None | $114 |
| 2020 | 8 | 27 | None | $468 |
| 2019 | 6 | 44 | None | $417 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Kowa Pharmaceuticals America | Livalo | $27 | 1 payment
|
| Genzyme | Dupixent | $25 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $22 | 1 payment
|
| Merck Sharp & Dohme | Nexplanon | $22 | 1 payment
|
| Amgen | Aimovig | $19 | 1 payment
|
See all 5 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2021-06-04 | Jardiance | $22 |
| Genzyme | Meals · 2021-05-27 | Dupixent | $25 |
| Merck Sharp & Dohme | Meals · 2021-04-14 | Nexplanon | $22 |
| Amgen | Meals · 2021-04-07 | Aimovig | $19 |
| Kowa Pharmaceuticals America | Meals · 2021-02-10 | Livalo | $27 |
See earlier years (2020, 2019)
2020: $468
| Amgen | Aimovig | $154 | 5 payments
|
| Zyla Life Sciences | Sprix | $137 | 14 payments
|
| Merck Sharp & Dohme | Nexplanon | $74 | 2 payments
|
| Allergan | Ubrelvy | $38 | 2 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $23 | 1 payment
|
| IBSA Pharma | Tirosint | $23 | 1 payment
|
| Lilly USA | Emgality | $12 | 1 payment
|
| Assertio Therapeutics | Cambia | $7 | 1 payment
|
2019: $417
| Zyla Life Sciences | Zorvolex | $203 | 34 payments
|
| Sanofi-Aventis U.S. | Toujeo | $82 | 4 payments
|
| Arbor Pharmaceuticals | Edarbi | $63 | 3 payments
|
| AbbVie | Creon | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $23 | 1 payment
|
| Genentech USA | Xofluza | $22 | 1 payment
|
Professional record
- NPI
- 1417034083
- Licence
- CA A76894California A76894: Surrendered
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 957 Colonial Ln, Palo Alto, CA, 94303
- NPI first listed
- 2006-11-01
- NPI last updated
- 2013-03-06
This is when the NPI record was last certified, not a medical board exam.